Science and Research

NEW ENGLAND JOURNAL OF MEDICINE

Previous Volume 357:1903-1915 November 8, 2007 Number 19

Duration of Humoral Immunity to Common Viral and Vaccine Antigens
Ian J. Amanna, Ph.D., Nichole E. Carlson, Ph.D., and Mark K. Slifka, Ph.D.

Original Article

PubMed Citation

ABSTRACT

Background Maintenance of long-term antibody responses is critical for protective immunity against many pathogens. However, the duration of humoral immunity and the role played by memory B cells remain poorly defined.

Methods We performed a longitudinal analysis of antibody titers specific for viral antigens (vaccinia, measles, mumps, rubella, varicella–zoster virus, and Epstein–Barr virus) and nonreplicating antigens (tetanus and diphtheria) in 45 subjects for a period of up to 26 years. In addition, we measured antigen-specific memory B cells by means of limiting-dilution analysis, and we compared memory B-cell frequencies to their corresponding serum antibody levels.

Results Antiviral antibody responses were remarkably stable, with half-lives ranging from an estimated 50 years for varicella–zoster virus to more than 200 years for other viruses such as measles and mumps. Antibody responses against tetanus and diphtheria antigens waned more quickly, with estimated half-lives of 11 years and 19 years, respectively. B-cell memory was long-lived, but there was no significant correlation between peripheral memory B-cell numbers and antibody levels for five of the eight antigens tested.

Conclusions These studies provide quantitative analysis of serologic memory for multiple antigens in subjects followed longitudinally over the course of more than one decade. In cases in which multiple exposures or repeated vaccinations were common, memory B-cell numbers did not correlate with antibody titers. This finding suggests that peripheral memory B cells and antibody-secreting plasma cells may represent independently regulated cell populations and may play different roles in the maintenance of protective immunity.


http://www.newsday.com:80/services/newspaper/printedition/monday/health/ny-hsvacc125457394nov12,0,3028259.story

Newsday.com

Report: Vaccine booster shots may be unnecessary
BY DELTHIA RICKS

delthia.ricks@newsday.com

November 12, 2007

Vaccines have drawn an intense spotlight in recent years, and a study published last week raised a new question in the debate: Do Americans overvaccinate?

Scientists writing in the New England Journal of Medicine found that immunity lasts far longer than previously believed, suggesting that fewer booster shots may be warranted in adults. Still other doctors are wondering whether new vaccine approaches would better aid children.

At least one doctor would like to see childhood vaccinations spread out over a longer period of time.

Dr. Mark Slifka, an associate scientist with the Vaccine and Gene Therapy Institute in Oregon, wanted to know how long immunity lasts after vaccination or infection. He and his colleagues went into the study with a lot of strong hypotheses and "expected to see long-lived immunity following a viral infection and relatively short-lived immunity after vaccination." Those notions, Slifka and his team said, are the reasoning for booster shots.

To his surprise, the research revealed that the immunity the body marshals after vaccination with tetanus and diphtheria lasted far longer than scientists had once believed. Immunity that arose after certain viral infections, Slifka and collaborators discovered, were essentially maintained for life.

Although it is important for the country to abide by vaccination as a vital public health tool, Slifka reported in the journal, it also is important to understand that boosters are not always necessary.

"We also need to mention that overvaccinating the population poses no health or safety concerns," he said, adding "it may just be unnecessary under certain circumstances."

Dr. Len Horovitz, a pulmonary physician at Lenox Hill Hospital in Manhattan, said while the concept of overvaccination may sound radical and new, doctors have had the power for years to test a person's immunity after initial vaccination. Horovitz says he always tests students who come to see him prior to their first year of college. If they need a booster, he gives it.

"It is possible to prevent this phenomenon," Horovitz said, referring to overvaccination, "by testing for antibodies." These immune-system proteins develop in the aftermath of vaccination. Antibodies are stimulated in the presence of a key protein called an antigen, a protein introduced by vaccination or infection.

The body "remembers" antigens through highly specialized, all-knowing constituents of the immune system: B cells, whose role is never to forget. When that memory fails, it can be reactivated with a booster shot.

"To determine whether an MMR booster is needed," Horovitz said of the mumps-measles-rubella shot, "antibody testing for each antigen can be done so that an unnecessary vaccine is not administered.

"A lot of doctors do not test to see if a patient is still immune. When kids go to college, the university wants a kid to get a booster. It's very possible that a booster isn't needed - and you can test to get an answer. But there are a lot of doctors who'll say, 'Let's just give the kid a booster.'"

Dr. Robert W. Sears, a vaccine expert and author of "The Vaccine Book," said parents of young children also use the term "overvaccination," but in a different way. They want to know whether vaccinations can be spread out to avoid a child's receiving so many shots at once.

"This is the single most important topic that I am most passionate about," Sears said. "Parents are concerned that simultaneous vaccines given to babies at an early age may be overwhelming to the infants' systems."

Just as Slifka sees no need for unnecessary boosters, Sears says it is possible to spread out vaccinations for children and still provide them with the same level of vital immunity to communicable diseases.

"Vaccination is definitely important," Sears said. "Vaccines have played a tremendous role in eliminating or at least limiting certain diseases in our population."

But he adds that spreading out the shots is far less traumatic and does not compromise the benefit of immunization.


















JABS is funded only by donation from well-wishers and those that find JABS helpful. Please help if you can by clicking here.

and.